StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research report sent to investors on Tuesday. The firm issued a hold rating on the software maker’s stock.
Veradigm Stock Up 5.0 %
MDRX opened at $10.55 on Tuesday. The business’s 50 day moving average is $9.80 and its 200-day moving average is $9.59. Veradigm has a twelve month low of $5.01 and a twelve month high of $12.66.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC bought a new stake in shares of Veradigm Inc. (NASDAQ:MDRX – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- Using the MarketBeat Dividend Tax Calculator
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- CD Calculator: Certificate of Deposit Calculator
- Netflix Is On Track To Hit $1,000 By Christmas
- 5 discounted opportunities for dividend growth investors
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
